Total Payments
$2,885
2023 Payments
$446.63
Companies
22
Transactions
82
Medicare Patients
9,670
Medicare Billing
$924,909
Payment Breakdown by Category
Food & Beverage$2,725 (94.4%)
Education$160.63 (5.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,725 | 79 | 94.4% |
| Education | $160.63 | 3 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $635.80 | 17 | $0 (2023) |
| Astellas Pharma US Inc | $404.50 | 16 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $360.08 | 13 | $0 (2022) |
| PFIZER INC. | $193.78 | 5 | $0 (2020) |
| UroGen Pharma, Inc. | $170.87 | 1 | $0 (2023) |
| NeoTract Inc. | $155.98 | 3 | $0 (2019) |
| Myriad Genetic Laboratories, Inc. | $139.47 | 2 | $0 (2021) |
| Augmenix, Inc. | $137.26 | 1 | $0 (2018) |
| PROCEPT BioRobotics Corporation | $125.82 | 1 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $119.69 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $446.63 | 10 | Janssen Biotech, Inc. ($173.85) |
| 2022 | $291.19 | 9 | PROCEPT BioRobotics Corporation ($125.82) |
| 2021 | $388.14 | 6 | Janssen Biotech, Inc. ($209.98) |
| 2020 | $180.99 | 4 | PFIZER INC. ($125.00) |
| 2019 | $528.73 | 17 | Janssen Biotech, Inc. ($158.50) |
| 2018 | $758.19 | 25 | Astellas Pharma US Inc ($222.71) |
| 2017 | $291.33 | 11 | Endo Pharmaceuticals Inc. ($185.65) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Oncology | ||||||
| 09/07/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $170.87 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/18/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Urology | ||||||
| 06/22/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Urology | ||||||
| 06/08/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $125.49 | General |
| Category: Oncology | ||||||
| 06/01/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Oncology | ||||||
| 06/01/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: Oncology | ||||||
| 05/11/2023 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Continence Care | ||||||
| 04/13/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Urology | ||||||
| 03/30/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Urology | ||||||
| 12/09/2022 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: OS | ||||||
| 10/19/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Continence Care | ||||||
| 09/09/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $20.96 | General |
| Category: Urology | ||||||
| 03/17/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Prostate Cancer | ||||||
| 03/10/2022 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 02/01/2022 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $125.82 | General |
| Category: Urology | ||||||
| 01/27/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: UROLOGY | ||||||
| 01/20/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Continence Care | ||||||
| 01/13/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 11/16/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Oncology | ||||||
| 10/28/2021 | Myriad Genetic Laboratories, Inc. | BRACAnalysis CDx (Device) | Food and Beverage | Cash or cash equivalent | $14.88 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 07/13/2021 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Prostate Cancer | ||||||
| 07/01/2021 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX, EDEX | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: UROLOGY | ||||||
| 04/28/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $85.00 | General |
| Category: Oncology | ||||||
| 03/18/2021 | Myriad Genetic Laboratories, Inc. | BRACAnalysis CDx (Device) | Food and Beverage | Cash or cash equivalent | $124.59 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,226 | 1,844 | $407,004 | $94,887 |
| 2022 | 22 | 2,369 | 11,659 | $1.0M | $273,527 |
| 2021 | 28 | 2,992 | 12,795 | $1.2M | $312,001 |
| 2020 | 23 | 3,083 | 4,649 | $1.1M | $244,493 |
Total Patients
9,670
Total Services
30,947
Medicare Billing
$924,909
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 450 | 749 | $169,364 | $48,246 | 28.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 69 | 78 | $55,023 | $14,016 | 25.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 101 | $69,049 | $13,719 | 19.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $16,057 | $3,754 | 23.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 58 | 69 | $9,391 | $2,663 | 28.4% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 11 | 11 | $9,229 | $2,630 | 28.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 15 | 38 | $9,582 | $1,848 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $6,022 | $1,804 | 30.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 112 | 165 | $43,758 | $1,311 | 3.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 28 | $3,532 | $1,181 | 33.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 232 | 304 | $3,390 | $1,033 | 30.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 14 | 16 | $4,606 | $854.75 | 18.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $3,579 | $779.35 | 21.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 23 | $2,602 | $641.24 | 24.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 147 | 186 | $1,821 | $404.80 | 22.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 4,680 | $209,274 | $80,037 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 697 | 1,174 | $265,465 | $77,535 | 29.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 124 | 149 | $105,108 | $28,294 | 26.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 19 | 171 | $116,904 | $24,477 | 20.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 137 | 137 | $46,803 | $11,078 | 23.7% |
| J9155 | Injection, degarelix, 1 mg | Office | 2022 | 12 | 3,440 | $29,412 | $11,051 | 37.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 161 | 186 | $25,315 | $8,141 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 54 | $18,066 | $5,375 | 29.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 54 | 59 | $19,194 | $4,990 | 26.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 49 | 131 | $16,527 | $4,329 | 26.2% |
About Dr. Kendall Wise, MD
Dr. Kendall Wise, MD is a Urology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831252014.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kendall Wise, MD has received a total of $2,885 in payments from pharmaceutical and medical device companies, with $446.63 received in 2023. These payments were reported across 82 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,725).
As a Medicare-enrolled provider, Wise has provided services to 9,670 Medicare beneficiaries, totaling 30,947 services with total Medicare billing of $924,909. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Naples, FL
- Active Since 12/18/2006
- Last Updated 04/20/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1831252014
Products in Payments
- XTANDI (Drug) $466.29
- ERLEADA (Drug) $383.83
- Erleada (Drug) $371.66
- XIAFLEX (Biological) $291.11
- JELMYTO (Drug) $170.87
- UroLift (Device) $155.98
- BRACAnalysis CDx (Device) $139.47
- SpaceOAR (Device) $137.26
- AQUABEAM ROBOTIC SYSTEM (Device) $125.82
- ELIGARD (Drug) $112.50
- AVEED (Biological) $68.97
- SpeediCath (Device) $68.51
- PROVENGE (Drug) $67.59
- Myrbetriq (Drug) $62.61
- MYRBETRIQ (Drug) $56.27
- Prolia (Biological) $40.27
- GEMTESA (Drug) $39.69
- Androgel (Drug) $26.58
- FIRMAGON (Drug) $20.93
- NOCDURNA (Drug) $19.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Naples
Dr. Rolando Rivera, M.d, M.D
Urology — Payments: $414,006
Urology $414,006
Dr. David Wilkinson, Md, MD
Urology — Payments: $219,283
Urology $219,283
Dr. David K Ornstein, Md, MD
Urology — Payments: $29,054
Urology $29,054
Dr. Jonathan Jay, Md, MD
Urology — Payments: $25,036
Urology $25,036
Joanna Chon, M.d, M.D
Urology — Payments: $11,763
Urology $11,763
Paulos Yohannes, Md, MD
Urology — Payments: $10,386
Urology $10,386